Tag Archives: LTS

Dr. Thomas Hille, Pharmacist, LTS Lohmann Therapy Systems

dr-thomas-hilleDr. Thomas Hille is a pharmacist and obtained his postgraduate degrees from University of Bonn. He joined LTS in 1986. Currently he is heading a R&D lab developing TDS and oral thin films. Prior to LTS, he was with Knoll AG, Germany, heading a R & D lab developing solid dosage forms. Dr. Hille is co-inventor in more than 70 patents.

In the last two years he gave presentations in Marburg University, and Concept Heidelberg dealing with the quality by design (QbD) concept in the development of TDS and he was speaker in the A.F.E.R.A. congress and A.W.A conference presenting the pharmaceutical requirements in pressure sensitive adhesives and release liners, when used in TDS.

What was your inspiration to get into the industry?

During my education I got the opportunity to join an R & D lab of Henkel in Düsseldorf as a workshop student and was assigned to work in industrial R & D.

What is your favourite part about presenting to a live audience?

Presenting to a live audience gives you real-time feedback without any delay. This allows you to immediately understand whether or not you are doing a good job whilst presenting.

What will the audience gain from attending your webinar?

TDS are a niche within the pharmaceutical business and so is the knowledge about adhesion and pressure sensitive adhesives. The audience will gain an understanding which kind of physicochemical properties make a polymer a pressure sensitive adhesive (PSA).

Why is it important for the audience to understand the requirements for Pressure Sensitive Adhesives?

The knowledge about TDS in general and about PSAs in specific are key when developing a TDS. The understanding of polymer chemistry and hands-on experience is an important basis to fulfill those challenges.

Where is your favourite place in the world and why?

My favorite place in the world is the Rhine Valley from Basel up to Rotterdam and Antwerp, as this region is the back bone of the chemical and pharmaceutical industry in all of its facets.

Be sure to join Thomas and LTS in their upcoming webinar, “Transdermal Delivery Systems: What are the Requirements for Pressure Sensitive Adhesives?”. Register now!

Dr. Michael Komenda, Corporate Senior Director, Head of Analytical Development R&D, LTS Lohmann Therapy Systems


Dr. Michael Komenda has more than 10 years experience in analytical development in the pharmaceutical industry. He studied chemistry at the University of Cologne, Germany, and at the Research Center Jülich, Germany, where he gained his doctorate degree in chemistry. He joined the Pharmaceutical Industry in 2003 and has held various positions in analytical development at SCHWARZ BIOSCIENCES. After the merger with UCB, he became head of analytical development at the German site and lateron head of the Transdermal Center of Expertise within UCB. Since 2012 he is head of Analytical Development at LTS in Andernach, Germany

1. Why did you decide to do a webinar with Business Review Webinars?
In addition to workshops and conferences, webinars provide an easy access platform to share information with a broader audience at minimal or even no costs. For the audience, it is easily possible to have a look into a scientific field that may be of interest, without the need of spending money for travel, accomodation and fees. The investment is just an hour of time, which hopefully turns out to be a wise investment.

2. What are you looking forward to explaining to the audience?
I want to give people insight into the analytical testing of Transdermal Delivery Systems (TDS). Patches are still a niche market and only a relatively small number of companies have hands-on experience.

3. What is the ideal outcome you would like from doing the webinar?
The ideal outcome would be that scientists and others in product development understand that a patch is a valuable alternative to just another tablet development, and that suitable analytical techniques are available to support TDS development. For people who already work in that field, it would be interesting to trigger a scientific discussion on some open questions as follow-up.

4.  Where is your favorite place in the world and why?
My favorite place is Cologne, Germany. Come here and experience the city and its people, and you will know why.

5. What motivates you?
To do something meaningful and to develop a product or a process


Join Dr. Michael Komenda who will be presenting in LTS Lohmann Therapy Systems webinar ‘Analytic considerations for testing Transdermal Delivery Systems‘ on 19th November at 3PM London/10AM New York. Register here.

Rick Chan, PhD, Vice President, Research & Development at LTS Lohmann Therapy Systems

Rick Chanl

Dr Rick Chan is a pharmacist, who obtained his postgraduate degrees from the University of London. He joined LTS in 2011 and is responsible for oral thin film R&D work globally. Prior to LTS, he was a Senior Director with GSK and its legacy companies in Product Development, New Product Research and New Opportunities, most notably in Pain Management and Smoking Cessation. He has worked internationally in Australia, Asia Pacific, Japan, and in the USA, and was a member of the GSK Drug Delivery Technology Steering Committee.

1. Why did you decide to do a webinar with Business Review Webinars?

It is a broader reach to a larger audience around the globe. This makes dissemination of information more effective. Apart from that, my business partner thinks it is a great idea!

2. What will the audience gain from attending your webinar?

Understand the potential applications of oral thin film and their suitability  when evaluating drug delivery systems for their molecules.

3. What’s your favourite thing about presenting to a live audience?

Engagement and interaction

4. Who or what inspired you to get into the industry?

I worked in community and hospital pharmacy in the summer vacations during my undergraduate years. I found them rewarding. When I was about to finish my final year of study, I was encouraged to apply and won an scholarship for my MSc in Pharmaceutical Technology at  University of London. I was privileged to have met my mentors – Prof Neiton Pilpel and Prof Mike Newton; both of whom became my academic supervisors at different stages in my PhD study. As they say, the rest is history!

5. What one item would you take with you to a desert island?

My guitar and sheet music.

Join Rick who will be presenting in LTS Lohmann Therapy Systems webinar ‘Oral Thin Films: New opportunities for oral drug delivery?‘ on 5th May at 3PM London/10AM New York.

Dr. Peter Klaffenbach, Head of Pharmaceutical Development, LTS Lohmann Therapy Systems

Peter Klaffenbach
Dr. Peter Klaffenbach has been in transdermal drug delivery systems development for over 20 years and is now in charge of pharmaceutical development of LTS. Prior to joining LTS, Peter was managing director at the German drug delivery company Labtec (now tesa-Labtec) and head of pharmaceutical development at 3M drug delivery in Germany.

1. Why did you decide to do a webinar with Business Review Webinars?

Actually, my marketing department thought that a webinar could be the right platform to reach an interested audience of professionals to share our knowledge of transdermal drug delivery. Patch technology is still a niche – conferences are rare and expensive. Webinars represent a modern and effective way to discuss these kinds of topics with the industry.

2. What are you looking forward to explaining to the audience?

I’m looking forward to share our vision. That is that transdermal systems are not only an excellent option for lifecycle management of established APIs, but the technology should also be considered very early in NCE development and considered as a first line dosage form.

3. What is the ideal outcome you would like from doing the webinar?

If some of the attendees would consider a patch as an alternative to a tablet as part of the initial drug product development, this would be a great outcome.

4. Where is your favourite place in the world and why?

Anywhere, as long it is underwater. Why? Because underwater we need to refocus our senses and we can enjoy life in three dimensions.

5. What motivates you?

To help patients to deal with their problems a little more easily by providing solutions that meet their needs.

Peter will be presenting his webinar ‘Transdermal Drug Delivery: Is it feasible for your drug?‘ on the 25th November at 10am New York/3pm London. Click here to read more and register.